New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease ...

Retinitis Pigmentosa (RP) is a rare genetic eye disorder that causes the retina’s cells to break down over time, leading to ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

Paige and Nora Wagner of Duluth don’t share the typical sisterly bond. They’re bonding over what most would see as a situation that could bring anyone down. “I couldn’t see in the dark. So, my mom ...

Luke's parents are taking him on sightseeing trips as his genetic disorder slowly causes blindness. PHOENIX — It’s a powerful ...

Researchers have uncovered the 3D structure of RBP3, a key protein in vision, revealing how it transports retinoids and fatty ...

Nanoscope Therapeutics has reported data from a mid-stage clinical trial that suggests its optogenetic therapy based on light-sensitive molecules is an effective treatment for incurable eye ...

It seeks to understand the process of trait inheritance from parents to offspring, including the molecular structure and function of genes, gene behaviour in the context of a cell or organism (e.g ...